Looking at brain activity in adults with anemia using near-infrared light
Uses a light-based brain scan to study thinking networks in adults with anemia.
Plain-language title generated from the registry record
Registry title: Brain Cognitive Network Abnormalities in Anemia Patients Using fNIRS
Key facts
- Where
- Tianjin, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT07578675, who can take part
Where in China
- Regenerative Medicine CenterTianjin, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Institute of Hematology & Blood Diseases Hospital, China
- Trial code
- NCT07578675
- Record updated
- 18 September 2026
- Original description
Anemia is a global public health concern and is closely linked to dysfunction of brain cognitive neural networks, a key mechanism underlying cognitive impairment. Such deficits-including declines in memory, learning, processing speed, and executive function-reduce daily living abilities and increase risks of falls and depression.Read full original descriptionShow less
Construction of Abnormal Projection Regions of Cognitive Neural Networks in Patients With Anemia Using Functional Near-Infrared Spectroscopy (fNIRS)
Anemia is a global public health concern and is closely linked to dysfunction of brain cognitive neural networks, a key mechanism underlying cognitive impairment. Such deficits-including declines in memory, learning, processing speed, and executive function-reduce daily living abilities and increase risks of falls and depression.
Functional near-infrared spectroscopy (fNIRS) enables real-time monitoring of oxygenated and deoxygenated hemoglobin fluctuations, reflecting brain network function. This study aims to identify affected neural network regions in anemic patients and visualize connectivity changes using heatmaps and arc-based mapping. The findings will support early detection of cognitive impairment and guide precise clinical interventions, ultimately informing individualized treatment strategies to enhance therapeutic outcomes and quality of life.
Inclusion: Diagnosis of anemia; First hospitalization; Male or female, aged 18-65 years; Willing and able to comply with the requirements for this study and written informed consent.
Exclusion: History of psychiatric illness; History of severe brain disease; Subjects that the investigator believes have other reasons that make them unsuitable for inclusion in this study.